Video
Examining 10-year postop data on epi-off CXL for keratoconus, ectasia
Author(s):
Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.
Steven Greenstein, MD, of the Cornea and Laser Institute (Teaneck, NJ), reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients who underwent laser refractive surgery.
Read the article: CXL effects remain generally stable 10 years post-treatment
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
